Results 211 to 220 of about 1,823,579 (281)

A 73‐Year‐Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT A 73‐year‐old man presented with progressive weakness and atrophy predominantly affecting the distal finger flexors and quadriceps muscles. Electrophysiological studies demonstrated mixed myogenic and neurogenic features. Muscle MRI showed inflammatory changes, and muscle biopsy revealed granulomatous myositis with histologic features ...
Mehmet Can Sari, Arens Taga, Sonya Ulrike Steele, Ahmet Hoke   +3 more
wiley   +1 more source

Letter to the Editor Re: "Preferred Retinal Locus in Juvenile Macular Dystrophy". [PDF]

Turk J Ophthalmol
Habib E.
europepmc   +1 more source

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Effectiveness of Anapanasati Meditation on Internal Locus of Control, Psychological Well-being, Resilience and Altruism Among Orphan Adolescents. [PDF]

Ann Neurosci
Basu T, Dangwal P, Deodar M, Chaurasiya J.   +3 more
europepmc   +1 more source

Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann, Theresa Lüth, Susen Schaake, Carolin Gabbert, Marius Möller, Hauke Busch, Katja Lohmann, Jonas A. Gustafson, Danny E. Miller, Kensuke Daida, Manabu Funayama, Nobutaka Hattori, Samia Ben Sassi, Faycel Hentati, Matthew J. Farrer, Kristian K. Ullrich, Christine Klein, Joanne Trinh   +17 more
wiley   +1 more source

Genome-wide association analyses highlight the role of the intestinal molecular environment in human gut microbiota variation. [PDF]

Nat Genet
Dekkers KF, Pertiwi K, Baldanzi G, Lundmark P, Hammar U, Moksnes MR, Coward E, Nethander M, Salih GA, Miari M, Nguyen D, Sayols-Baixeras S, Eklund AC, Holm JB, Nielsen HB, Volpiano CG, Méric G, Thangam M, Hakaste L, Tuomi T, Ahlqvist E, Smith CA, Allen M, Reimann F, Gribble FM, Ohlsson C, Hveem K, Melander O, Nilsson PM, Engström G, Smith JG, Michaëlsson K, Ärnlöv J, Orho-Melander M, Fall T.   +34 more
europepmc   +1 more source

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I. Bohnen, Roger L. Albin   +6 more
wiley   +1 more source

Fruit weight regulation by a paralog of Cell Size Regulator (CSR) in tomato and other crops. [PDF]

Theor Appl Genet
Feng Q, Pereira L, Sapkota M, Karnatam KS, Wang Y, Nimmakayala P, Reddy UK, van der Knaap E.   +7 more
europepmc   +1 more source

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen, Ceren Tozlu, Tina Roostaei, Fatoumata Diallo, Kaho Onomichi, Jiyeon Son, Zongqi Xia, Philip L. De Jager   +7 more
wiley   +1 more source

Molecular polymorphisms that underlie trait variation in crops: Lessons learned from soybean. [PDF]

Plant Genome
Espina MJC, Lorenz AJ, Stupar RM.
europepmc   +1 more source